NDC 36987-2764
Red Maple
Red Maple
Red Maple is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Acer Rubrum Pollen.
| Product ID | 36987-2764_69cd05e6-a993-428b-9b0c-0235126ba63b |
| NDC | 36987-2764 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Red Maple |
| Generic Name | Red Maple |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | ACER RUBRUM POLLEN |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2764-2
10 mL in 1 VIAL, MULTI-DOSE (36987-2764-2)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2764-1 [36987276401]
Red Maple INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2764-4 [36987276404]
Red Maple INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2764-3 [36987276403]
Red Maple INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2764-2 [36987276402]
Red Maple INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ACER RUBRUM POLLEN | .1 g/mL |
OpenFDA Data
Pharmacological Class
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
- Non-Standardized Pollen Allergenic Extract [EPC]
NDC Crossover Matching brand name "Red Maple" or generic name "Red Maple"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-2757 | Red Maple | Red Maple |
| 36987-2758 | Red Maple | Red Maple |
| 36987-2759 | Red Maple | Red Maple |
| 36987-2760 | Red Maple | Red Maple |
| 36987-2761 | Red Maple | Red Maple |
| 36987-2762 | Red Maple | Red Maple |
| 36987-2763 | Red Maple | Red Maple |
| 36987-2764 | Red Maple | Red Maple |
| 49288-0322 | Red Maple | Red Maple |
| 0268-6634 | ACER RUBRUM POLLEN | Red Maple |
| 0268-6724 | ACER RUBRUM POLLEN | Red Maple |
Trademark Results [Red Maple]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RED MAPLE 88078672 not registered Live/Pending |
Henan Xinchi International Trading Co.,Ltd. 2018-08-15 |
 RED MAPLE 88078652 not registered Live/Pending |
Henan Xinchi International Trading Co.,Ltd. 2018-08-15 |
 RED MAPLE 88078634 not registered Live/Pending |
Henan Xinchi International Trading Co.,Ltd. 2018-08-15 |
 RED MAPLE 85092866 3937547 Live/Registered |
Red Maple Technologies, Inc. 2010-07-26 |
 RED MAPLE 77935745 3869570 Live/Registered |
RED MAPLE TECHNOLOGIES, INC. 2010-02-15 |
 RED MAPLE 77416274 4007906 Dead/Cancelled |
Cranberry Products of Canada Limited 2008-03-07 |
 RED MAPLE 76085134 not registered Dead/Abandoned |
Star Business Center, Inc. 2000-07-07 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.